|
Author Archive: AZBio
HTG Expands Data Analytics Capabilities for Customers with the Release of HTG EdgeSeq Reveal Data Analytics Software Version 1.2.0
HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, announced the release of its HTG EdgeSeqTM Reveal data analytics software, version 1.2.0. HTG EdgeSeq Reveal is a powerful software product that can enable customers to streamline their analysis of samples processed on the HTG EdgeSeq platform.Continue reading
AZBio Earns GuideStar’s Highest Seal of Transparency
Platinum Seal Allows Donors to Focus on Progress and Results
Continue reading
Noted Oncologist Dr. William Cance Named Interim Director of UA Cancer Center
The appointment was made by UA Senior Vice President for Health Sciences Michael D. Dake, MD.
“Dr. Cance has made enormous strides in Phoenix and across the state to establish a culture of collaboration to advance cancer care and treatment,” Dr. Dake said. “His keen focus on collaboration will enhance programs, advance basic science, reduce disparities and elevate the UA Cancer Center’s reputation for excellence in service to our state.”Continue reading
Science Foundation Arizona positions its future with ASU
Effective July 1, Science Foundation Arizona (SFAz), the nation’s largest, leading-edge, public-private partnership that connects the research capabilities in Arizona’s three universities with the needs of Arizona’s business and industry is positioning its future at Arizona State University. It will remain an independent 501c3 located at SkySong and will be known as SFAz@ASU.Continue reading
ASU researcher starts clinical study to improve diagnostic tests for lung infections
Just breathe. If detecting lung infections were as simple as taking a breath, patients with cystic fibrosis would be able to seek treatment sooner.
People with cystic fibrosis who get bacterial infections in their lungs often experience a decline in their lung health — which ultimately shortens their life spans. However, if the infections are caught and treated early enough, these same patients can live longer, healthier lives.Continue reading
BIO Shares Member Perspectives on the use of Real World Evidence
As policy makers and regulators consider how best to incorporate the use of of real-world evidence (RWE) and real-world data (RWD) for changes to the label of an approved product, The Biotechnology Innovation Organization (BIO) has prepared a white paper to offer the perspectives of BIO member companies.Continue reading
Report Highlights Best Practices in Bioscience Economic Development
Every two years, the Biotechnology Innovation Organization (BIO) publishes a biennial BIO Economic Development Best Practices Report that catalogs state and regional economic development initiatives. The best practice examples contained within this report highlight the critical facets that foster high-performing industry and the long-term success it has maintained. The report reaffirms that successful industry development initiatives are built upon the following four key building blocks for company creation and expansion:Continue reading
